01 1Fagron Inc
02 1Jubilant HollisterStier LLC
03 1LETCO MEDICAL, LLC
04 1Medisca Inc.
05 1North China Pharmaceutical Huasheng Co. Ltd.
06 1Professional Compounding Centers of America dba PCCA
07 3Synbiotics Limited
08 1Xellia Pharmaceuticals ApS
09 1Zhejiang Tiantai Pharmaceutical Co., Ltd.
01 1AMPHOTERICIN B
02 9Amphotericin B
03 1amphotericin b
01 2China
02 1Denmark
03 3India
04 1Netherlands
05 3U.S.A
06 1United Kingdom
NDC Package Code : 51552-0304
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-01-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-1173
Start Marketing Date : 2012-02-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0191
Start Marketing Date : 2011-05-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55500-0001
Start Marketing Date : 2017-01-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (500g/500g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1726
Start Marketing Date : 2013-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 63622-0123
Start Marketing Date : 2011-01-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63622-0124
Start Marketing Date : 2011-01-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63622-0125
Start Marketing Date : 2019-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 45932-0008
Start Marketing Date : 1998-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39635-0003
Start Marketing Date : 2022-05-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Amphotericin B manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amphotericin B, including repackagers and relabelers. The FDA regulates Amphotericin B manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amphotericin B API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amphotericin B manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amphotericin B supplier is an individual or a company that provides Amphotericin B active pharmaceutical ingredient (API) or Amphotericin B finished formulations upon request. The Amphotericin B suppliers may include Amphotericin B API manufacturers, exporters, distributors and traders.
click here to find a list of Amphotericin B suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amphotericin B as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amphotericin B API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amphotericin B as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amphotericin B and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amphotericin B NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amphotericin B suppliers with NDC on PharmaCompass.
We have 9 companies offering Amphotericin B
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
